- Home
- RELL vs GLSI Comparison
RELL vs GLSI Comparison
Compare RELL & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- GLSI
- Stock Information
- Founded
- RELL 1947
- GLSI 2006
- Country
- RELL United States
- GLSI United States
- Employees
- RELL N/A
- GLSI N/A
- Industry
- RELL Electronic Components
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- GLSI Health Care
- Exchange
- RELL Nasdaq
- GLSI Nasdaq
- Market Cap
- RELL 138.8M
- GLSI 134.6M
- IPO Year
- RELL N/A
- GLSI 2020
- Fundamental
- Price
- RELL $9.93
- GLSI $10.81
- Analyst Decision
- RELL
- GLSI Strong Buy
- Analyst Count
- RELL 0
- GLSI 1
- Target Price
- RELL N/A
- GLSI $39.00
- AVG Volume (30 Days)
- RELL 41.3K
- GLSI 47.7K
- Earning Date
- RELL 07-23-2025
- GLSI 08-13-2025
- Dividend Yield
- RELL 2.45%
- GLSI N/A
- EPS Growth
- RELL N/A
- GLSI N/A
- EPS
- RELL N/A
- GLSI N/A
- Revenue
- RELL $204,394,000.00
- GLSI N/A
- Revenue This Year
- RELL $9.48
- GLSI N/A
- Revenue Next Year
- RELL $4.10
- GLSI N/A
- P/E Ratio
- RELL N/A
- GLSI N/A
- Revenue Growth
- RELL N/A
- GLSI N/A
- 52 Week Low
- RELL $7.57
- GLSI $8.06
- 52 Week High
- RELL $15.51
- GLSI $17.00
- Technical
- Relative Strength Index (RSI)
- RELL 54.78
- GLSI 67.60
- Support Level
- RELL $9.71
- GLSI $8.97
- Resistance Level
- RELL $10.06
- GLSI $11.52
- Average True Range (ATR)
- RELL 0.32
- GLSI 0.51
- MACD
- RELL 0.02
- GLSI 0.21
- Stochastic Oscillator
- RELL 62.97
- GLSI 75.17
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.